Call for input regarding electric field therapy (Optune) for the New Methods framework

21

Sep 2022

In 2013, Norway established a framework, "New Methods," for the introduction of innovations into the health care system through either a national or hospital-based health technology assessment. In this framework, all innovations should undergo HTA before being funded.

In September 2022, Ordering Forum for New Methods has invited interested parties regarding electric field therapy (Optune, Tumor Treating Fields) alone or in combination with drugs for certain groups of glioblastoma patients, based on genome sequencing and biomarkers (indication II).

The technology was previously evaluated within New Methods in combination with temozolomide for the treatment of glioblastoma; the Decision of 2020 can be seen here.

Information shall be submitted before November 8, 2022. Ordering Forum will be held on November 21, 2022, and will decide whether the method will undergo evaluation at the national level.

See more details in Norwegian here and here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

23

Sep 2022

On September 5, 2022, it was announced that the Interterritorial Council for the Spanish National Health System (CISNS) approved the distribution of funds to the Autonomous Communities for the fight against cancer. The aim is to boost the screening programs for colorectal and cervical cancer.

Read more

20

Sep 2022

In late August 2022, the updated version of the DRG tariff system guide (Takstsystem) was released by the Danish Health Data Agency (Sundhedsdatastyrelsen). No new DRGs were introduced in the updated version of the DRG tariff system guide. However, two new groups were added to the List of special services, for which supplementary payment may be charged.

Read more

19

Sep 2022

On September 1, 2022, the Institute for Hospital Remuneration Systems (INeK) announced the start of the application process according to §6 (2) KHEntgG (New Examination and Treatment Methods, NUB) for 2023. The deadline for the submission of applications is October 31, 2022.

Read more

15

Sep 2022

On August 25, 2022, the Norwegian Directorate of Health announced the launch of the National screening program for colorectal cancer (Bowel screening program - Tarmscreeningprogrammet). All 55-year-old men and women will be included in the program and offered a test to identify invisible blood in the stool (fecal immunochemical test, FIT) every two years until the age of 65. Colonoscopy will be offered in case of positive FIT.

Read more

14

Sep 2022

The French National Authority for Health (HAS) released new recommendations about transitional coverage of medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in August 2022. One opinion was published regarding the cardiac resynchronization system WISE CRT-SYSTEM by EBR System.

Read more